Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Core Viewpoint - Keros Therapeutics, Inc. (KROS) is currently under investigation by Bronstein, Gewirtz & Grossman, LLC, which is encouraging stockholders to reach out for more information regarding the investigation [1] Group 1 - The investigation pertains to potential violations of securities laws by Keros Therapeutics [1] - Stockholders are being urged to contact the firm to understand the implications of the investigation [1] - The investigation may impact the stock performance and investor sentiment towards Keros Therapeutics [1]